Tyrosine phosphoproteomic profiling of TP53-mutant mouse tumor models, revealed unique up-regulation of the proto-oncogene, receptor tyrosine kinase (RTK) Mesenchymal–epithelial transition factor (MET) [39]. This evidence concerns the gene TP53 and neoplasm.